These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32061)

  • 1. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of kanamycin on evoked transmitter release. Reversal by 3,4-diaminopyridine.
    Molgó J; Lemeignan M; Uchiyama T; Lechat P
    Eur J Pharmacol; 1979 Jul; 57(1):93-7. PubMed ID: 38977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J; Lemeignan M; Lechat P
    J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.
    Horn AS; Lambert JJ; Marshall IG
    Br J Pharmacol; 1979 Jan; 65(1):53-62. PubMed ID: 216450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
    Thomsen RH; Wilson DF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aldrin-transdiol on neuromuscular facilitation and depression.
    Akkermans LM; van den Bercken J; van der Zalm J
    Eur J Pharmacol; 1975 Apr; 31(2):166-75. PubMed ID: 238851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitatory effects of 4-aminopyridine on strontium-mediated evoked and delayed transmitter release from motor nerve terminals.
    Molgó J; Lemeignan M; Guerrero S
    Eur J Pharmacol; 1982 Oct; 84(1-2):1-7. PubMed ID: 6128233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 4-aminopyridine on statistical parameters of transmitter release at the neuromuscular junction.
    Lundh H
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):343-6. PubMed ID: 38626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual action of ouabain on transmitter release at neuromuscular junctions of the frog.
    Brănişteanu DD; Proca B; Haulică ID
    J Pharmacol Exp Ther; 1979 Apr; 209(1):31-6. PubMed ID: 34716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the action of tetanus toxin at rat soleus neuromuscular junctions.
    Bevan S; Wendon LM
    J Physiol; 1984 Mar; 348():1-17. PubMed ID: 6716279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].
    Molgo J; Lemeignan M; Lechat P
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(21):1637-9. PubMed ID: 3292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Presynaptic effects of aminopyridines on the neuromuscular junction of vertebrates].
    Molgó J; Lemeignan M; Peradejordi F; Lechat P
    J Pharmacol; 1985; 16 Suppl 2():109-44. PubMed ID: 2417060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
    Uchiyama T; Molgo J; Lemeignan M
    Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):105-11. PubMed ID: 6245354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmitter mobilization at the frog neuromuscular junction.
    Alkadhi K; Volle RL
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):261-75. PubMed ID: 23083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
    Montoya GA; Molgó J; Lemeignan M; Lechat P
    Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interaction of 4-aminopyridine with neostigmine at the neuromuscular junction.
    Tierney PC; Kim YI; Johns TR
    Eur J Pharmacol; 1985 Sep; 115(2-3):241-7. PubMed ID: 2998823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.
    Miyamoto MD
    J Physiol; 1975 Aug; 250(1):121-42. PubMed ID: 240928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.